Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2004 Mar 15;378(Pt 3):727–734. doi: 10.1042/BJ20031377

Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity.

Paul C Evans 1, Huib Ovaa 1, Maureen Hamon 1, Peter J Kilshaw 1, Svetlana Hamm 1, Stefan Bauer 1, Hidde L Ploegh 1, Trevor S Smith 1
PMCID: PMC1224040  PMID: 14748687

Abstract

Ubiquitination regulates the stability and/or activity of numerous cellular proteins. The corollary is that de-ubiquitinating enzymes, which 'trim' polyubiquitin chains from specific substrate proteins, play key roles in controlling fundamental cellular activities. Ubiquitin is essential at several stages during the activation of NF-kappaB (nuclear factor kappaB), a central co-ordinator of inflammation and other immune processes. Ubiquitination is known to cause degradation of the inhibitory molecule IkappaBalpha (inhibitor of kappaB). In addition, activation of TRAF (tumour-necrosis-factor-receptor-associated factor) and IKKgamma (IkappaB kinase gamma)/NEMO (NF-kappaB essential modifier) signal adaptors relies on their modification with 'nonclassical' forms of polyubiquitin chains. Ubiquitin also plays a key role in determining cell fate by modulating the stability of numerous pro-apoptotic or anti-apoptotic proteins. The zinc-finger protein A20 has dual functions in inhibiting NF-kappaB activation and suppressing apoptosis. The molecular mechanisms of these anti-inflammatory and cytoprotective effects are unknown. Here we demonstrate that A20 is a de-ubiquitinating enzyme. It contains an N-terminal catalytic domain that belongs to the ovarian-tumour superfamily of cysteine proteases. A20 cleaved ubiquitin monomers from branched polyubiquitin chains linked through Lys48 or Lys63 and bound covalently to a thiol-group-reactive, ubiquitin-derived probe. Mutation of a conserved cysteine residue in the catalytic site (Cys103) abolished these activities. A20 did not have a global effect on ubiquitinated cellular proteins, which indicates that its activity is target-specific. The biological significance of the catalytic domain is unknown.

Full Text

The Full Text of this article is available as a PDF (228.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balakirev Maxim Y., Tcherniuk Sergey O., Jaquinod Michel, Chroboczek Jadwiga. Otubains: a new family of cysteine proteases in the ubiquitin pathway. EMBO Rep. 2003 May;4(5):517–522. doi: 10.1038/sj.embor.embor824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bignell G. R., Warren W., Seal S., Takahashi M., Rapley E., Barfoot R., Green H., Brown C., Biggs P. J., Lakhani S. R. Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet. 2000 Jun;25(2):160–165. doi: 10.1038/76006. [DOI] [PubMed] [Google Scholar]
  3. Borodovsky A., Kessler B. M., Casagrande R., Overkleeft H. S., Wilkinson K. D., Ploegh H. L. A novel active site-directed probe specific for deubiquitylating enzymes reveals proteasome association of USP14. EMBO J. 2001 Sep 17;20(18):5187–5196. doi: 10.1093/emboj/20.18.5187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Borodovsky Anna, Ovaa Huib, Kolli Nagamalleswari, Gan-Erdene Tudeviin, Wilkinson Keith D., Ploegh Hidde L., Kessler Benedikt M. Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem Biol. 2002 Oct;9(10):1149–1159. doi: 10.1016/s1074-5521(02)00248-x. [DOI] [PubMed] [Google Scholar]
  5. Brummelkamp Thijn R., Nijman Sebastian M. B., Dirac Annette M. G., Bernards René. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature. 2003 Aug 14;424(6950):797–801. doi: 10.1038/nature01811. [DOI] [PubMed] [Google Scholar]
  6. Chen Xin, Zhang Bing, Fischer Janice A. A specific protein substrate for a deubiquitinating enzyme: Liquid facets is the substrate of Fat facets. Genes Dev. 2002 Feb 1;16(3):289–294. doi: 10.1101/gad.961502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. De Valck D., Heyninck K., Van Criekinge W., Contreras R., Beyaert R., Fiers W. A20, an inhibitor of cell death, self-associates by its zinc finger domain. FEBS Lett. 1996 Apr 8;384(1):61–64. doi: 10.1016/0014-5793(96)00283-9. [DOI] [PubMed] [Google Scholar]
  8. De Valck D., Jin D. Y., Heyninck K., Van de Craen M., Contreras R., Fiers W., Jeang K. T., Beyaert R. The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases. Oncogene. 1999 Jul 22;18(29):4182–4190. doi: 10.1038/sj.onc.1202787. [DOI] [PubMed] [Google Scholar]
  9. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., Chen Z. J. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 2000 Oct 13;103(2):351–361. doi: 10.1016/s0092-8674(00)00126-4. [DOI] [PubMed] [Google Scholar]
  10. Evans P. C., Taylor E. R., Coadwell J., Heyninck K., Beyaert R., Kilshaw P. J. Isolation and characterization of two novel A20-like proteins. Biochem J. 2001 Aug 1;357(Pt 3):617–623. doi: 10.1042/0264-6021:3570617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Evans Paul C., Smith Trevor S., Lai Meng-Jiun, Williams Mark G., Burke David F., Heyninck Karen, Kreike Marja M., Beyaert Rudi, Blundell Tom L., Kilshaw Peter J. A novel type of deubiquitinating enzyme. J Biol Chem. 2003 Apr 7;278(25):23180–23186. doi: 10.1074/jbc.M301863200. [DOI] [PubMed] [Google Scholar]
  12. Fries K. L., Miller W. E., Raab-Traub N. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol. 1996 Dec;70(12):8653–8659. doi: 10.1128/jvi.70.12.8653-8659.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hatakeyama S., Yada M., Matsumoto M., Ishida N., Nakayama K. I. U box proteins as a new family of ubiquitin-protein ligases. J Biol Chem. 2001 Jul 2;276(35):33111–33120. doi: 10.1074/jbc.M102755200. [DOI] [PubMed] [Google Scholar]
  14. Hu Min, Li Pingwei, Li Muyang, Li Wenyu, Yao Tingting, Wu Jia-Wei, Gu Wei, Cohen Robert E., Shi Yigong. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell. 2002 Dec 27;111(7):1041–1054. doi: 10.1016/s0092-8674(02)01199-6. [DOI] [PubMed] [Google Scholar]
  15. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000;18:621–663. doi: 10.1146/annurev.immunol.18.1.621. [DOI] [PubMed] [Google Scholar]
  16. Kovalenko Andrew, Chable-Bessia Christine, Cantarella Giuseppina, Israël Alain, Wallach David, Courtois Gilles. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature. 2003 Aug 14;424(6950):801–805. doi: 10.1038/nature01802. [DOI] [PubMed] [Google Scholar]
  17. Krikos A., Laherty C. D., Dixit V. M. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J Biol Chem. 1992 Sep 5;267(25):17971–17976. [PubMed] [Google Scholar]
  18. Lee E. G., Boone D. L., Chai S., Libby S. L., Chien M., Lodolce J. P., Ma A. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science. 2000 Sep 29;289(5488):2350–2354. doi: 10.1126/science.289.5488.2350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Legler Daniel F., Micheau Olivier, Doucey Marie-Agnès, Tschopp Jürg, Bron Claude. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity. 2003 May;18(5):655–664. doi: 10.1016/s1074-7613(03)00092-x. [DOI] [PubMed] [Google Scholar]
  20. Li Muyang, Chen Delin, Shiloh Ariel, Luo Jianyuan, Nikolaev Anatoly Y., Qin Jun, Gu Wei. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature. 2002 Mar 31;416(6881):648–653. doi: 10.1038/nature737. [DOI] [PubMed] [Google Scholar]
  21. Makarova K. S., Aravind L., Koonin E. V. A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae. Trends Biochem Sci. 2000 Feb;25(2):50–52. doi: 10.1016/s0968-0004(99)01530-3. [DOI] [PubMed] [Google Scholar]
  22. Pickart C. M. Ubiquitin enters the new millennium. Mol Cell. 2001 Sep;8(3):499–504. doi: 10.1016/s1097-2765(01)00347-1. [DOI] [PubMed] [Google Scholar]
  23. Saigoh K., Wang Y. L., Suh J. G., Yamanishi T., Sakai Y., Kiyosawa H., Harada T., Ichihara N., Wakana S., Kikuchi T. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet. 1999 Sep;23(1):47–51. doi: 10.1038/12647. [DOI] [PubMed] [Google Scholar]
  24. Sarma V., Lin Z., Clark L., Rust B. M., Tewari M., Noelle R. J., Dixit V. M. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J Biol Chem. 1995 May 26;270(21):12343–12346. doi: 10.1074/jbc.270.21.12343. [DOI] [PubMed] [Google Scholar]
  25. Shi Chong-Shan, Kehrl John H. Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2). J Biol Chem. 2003 Feb 18;278(17):15429–15434. doi: 10.1074/jbc.M211796200. [DOI] [PubMed] [Google Scholar]
  26. Song H. Y., Rothe M., Goeddel D. V. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6721–6725. doi: 10.1073/pnas.93.13.6721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tang Eric D., Wang Cun-Yu, Xiong Yue, Guan Kun-Liang. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J Biol Chem. 2003 Jul 16;278(39):37297–37305. doi: 10.1074/jbc.M303389200. [DOI] [PubMed] [Google Scholar]
  28. Trompouki Eirini, Hatzivassiliou Eudoxia, Tsichritzis Theodore, Farmer Hannah, Ashworth Alan, Mosialos George. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature. 2003 Aug 14;424(6950):793–796. doi: 10.1038/nature01803. [DOI] [PubMed] [Google Scholar]
  29. Verma Rati, Aravind L., Oania Robert, McDonald W. Hayes, Yates John R., 3rd, Koonin Eugene V., Deshaies Raymond J. Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science. 2002 Aug 15;298(5593):611–615. doi: 10.1126/science.1075898. [DOI] [PubMed] [Google Scholar]
  30. Wilkinson K. D., Tashayev V. L., O'Connor L. B., Larsen C. N., Kasperek E., Pickart C. M. Metabolism of the polyubiquitin degradation signal: structure, mechanism, and role of isopeptidase T. Biochemistry. 1995 Nov 7;34(44):14535–14546. doi: 10.1021/bi00044a032. [DOI] [PubMed] [Google Scholar]
  31. Zetoune F. S., Murthy A. R., Shao Z., Hlaing T., Zeidler M. G., Li Y., Vincenz C. A20 inhibits NF-kappa B activation downstream of multiple Map3 kinases and interacts with the I kappa B signalosome. Cytokine. 2001 Sep 21;15(6):282–298. doi: 10.1006/cyto.2001.0921. [DOI] [PubMed] [Google Scholar]
  32. Zhang S. Q., Kovalenko A., Cantarella G., Wallach D. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. Immunity. 2000 Mar;12(3):301–311. doi: 10.1016/s1074-7613(00)80183-1. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES